Cis-platinum as second-line chemotherapy in advanced gastric adenocarcinoma. A phase II study of the EORTC gastrointestinal tract cancer cooperative group-Reference-Cited by-同舟云学术

Cis-platinum as second-line chemotherapy in advanced gastric adenocarcinoma. A phase II study of the EORTC gastrointestinal tract cancer cooperative group

Published:1985-11 Issue:11 Volume:21 Page:1321-1324
ISSN:0277-5379
Container-title:European Journal of Cancer and Clinical Oncology
language:en
Short-container-title:European Journal of Cancer and Clinical Oncology

Author:

Lacave A.J.,Wils J.,Diaz-Rubio E.,Clavel M.,Planting A.,Bleiberg H.,Duez N.,Dalesio O.

Publisher

Elsevier BV

Subject

Oncology

Reference20 articles.

1. Cancer of the stomach;MacDonald,1982

2. Methyl-CCNU (Me), 5-fluorouracil (F), adriamycin (A) (MeFA) versus MeF in advanced gastric cancer;Lacave,1979

3. 5-Fluorouracil, doxorubicin, mitomycin-C (FAM) combination chemotherapy for advanced gastric cancer;MacDonald;Ann Intern Med,1980

4. Phase II–III chemotherapy studies in advanced gastric cancer;The Gastrointestinal Tumor Study Group;Cancer Treat Rep,1979

5. An Eastern Cooperative Oncology Group evaluation of combinations of methyl-CCNU, mitomycin-C, adriamycin and 5-fluorouracil in advanced measurable gastric cancer (EST 2277);Douglas;J Clin Oncol,1984

Cited by 47 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Co-operative groups in the development of chemotherapy for gastric cancer;Japanese Journal of Clinical Oncology;2018-12-01

2. Challenges in first line chemotherapy and targeted therapy in advanced gastric cancer;Expert Review of Anticancer Therapy;2014-06-23

3. A FGFR2 inhibitor, Ki23057, enhances the chemosensitivity of drug-resistant gastric cancer cells;Cancer Letters;2011-08

4. Salvage chemotherapy of biweekly irinotecan plus S-1 (biweekly IRIS) in previously treated patients with advanced gastric cancer;Cancer Chemotherapy and Pharmacology;2011-02-16

5. Metastasiertes Magenkarzinom: Ist eine Zweitlinien-Chemotherapie sinnvoll?;DMW - Deutsche Medizinische Wochenschrift;2010-09